The Novel Plk Inhibitor Volasertib Overcomes Cytarabine Resistance in Acute Myeloid Leukemia

被引：0
|
作者：
Fu, Shuang [1 ]
Kelly, Kevin R. [2 ]
Espitia, Claudia M. [3 ]
Han, Yingchun [1 ]
Carraway, Hetty E. [4 ]
Advani, Anjali S. [4 ]
Maciejewski, Jaroslaw P. [4 ]
Sekeres, Mikkael A. [4 ]
Steffan, Nawrocki T. [3 ]
Carew, Jennifer S. [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[2] Univ So Calif, Los Angeles, CA USA
[3] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[4] Cleveland Clin, Cleveland, OH 44106 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Revival of the PLK1 Inhibitor Volasertib in Relapsed/Refractory Acute Myeloid Leukemia
    Michelson, Glenn
    Houston, Scott
    Leonardi, Chris
    Gu, Christine
    Lacher, Markus
    Wagner, Joseph
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S320 - S321
  • [2] RIGOSERTIB, A NOVEL RAS INHIBITOR, OVERCOMES AZACITIDINE RESISTANCE IN ACUTE MYELOID LEUKEMIA CELL LINES
    Cosenza, S.
    Oussenko, I.
    Divakar, S.
    Panda, G.
    Reddy, M.
    Ohnuma, T.
    Reddy, P.
    LEUKEMIA RESEARCH, 2015, 39 : S87 - S87
  • [3] Ningetinib, a novel FLT3 inhibitor, overcomes secondary drug resistance in acute myeloid leukemia
    Hu, Chuhong
    Zhang, Yvyin
    Yang, Jie
    Xu, Yanli
    Deng, Tingfen
    Li, Yumiao
    Xu, Shilin
    Wang, Shunqing
    Wang, Peihong
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [4] Targeting Myeloperoxidase Disrupts Mitochondrial Redox Balance and Overcomes Cytarabine Resistance in Human Acute Myeloid Leukemia
    Hosseini, Mohsen
    Rezvani, Hamid Reza
    Aroua, Nesrine
    Bosc, Claudie
    Farge, Thomas
    Saland, Estelle
    Guyonnet-Duperat, Veronique
    Zaghdoudi, Sonia
    Jarrou, Latifa
    Larrue, Clement
    Sabatier, Marie
    Mouchel, Pierre Luc
    Gotanegre, Mathilde
    Piechaczyk, Marc
    Bossis, Guillaume
    Recher, Christian
    Sarry, Jean-Emmanuel
    CANCER RESEARCH, 2019, 79 (20) : 5191 - 5203
  • [5] Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells
    Bista, Ranjan
    Lee, David W.
    Pepper, Oliver B.
    Azorsa, David O.
    Arceci, Robert J.
    Aleem, Eiman
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36 : 1 - 14
  • [6] Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells
    Ranjan Bista
    David W. Lee
    Oliver B. Pepper
    David O. Azorsa
    Robert J. Arceci
    Eiman Aleem
    Journal of Experimental & Clinical Cancer Research, 36
  • [7] Cross resistance to cytarabine in childhood acute myeloid leukemia
    Hubeek, I
    Peters, GJ
    Broekhuizen, AJF
    Zwaan, CM
    Van Wering, ER
    Creutzig, U
    Kaspers, GJL
    LEUKEMIA, 2003, 17 (03) : 680 - 680
  • [8] Modulation of cytarabine resistance in childhood acute myeloid leukemia
    Hubeek, I
    Peters, GJ
    Broekhuizen, AJF
    Zwaan, CM
    Creutzig, U
    Kaspers, GJL
    LEUKEMIA, 2003, 17 (03) : 681 - 681
  • [9] Problems related to resistance to cytarabine in acute myeloid leukemia
    Cros, E
    Jordheim, L
    Dumontet, C
    Galmarini, CM
    LEUKEMIA & LYMPHOMA, 2004, 45 (06) : 1123 - 1132
  • [10] Vincristine Overcomes Cytarabine Resistance in Acute Myeloid Leukemia By Suppression of ARHGAP18-Mediated Cellular Senescence
    Ren, Xiyang
    Yan, Haotian
    Zhou, Mei
    Wu, Fan
    Zhang, Qing
    Ding, Yangyang
    Li, Qian
    Wang, Huiping
    Xu, Caixian
    Wang, Jiyu
    Li, Cong
    Zhang, Wanqiu
    Liu, Linlin
    Chen, Ruotong
    Dong, Yi
    Dai, Wenjie
    Zhai, Zhimin
    Tao, Qianshan
    BLOOD, 2024, 144 : 2754 - 2754
12345